Vivos (RDGL) Common Equity (2010 - 2025)
Vivos (RDGL) posted Common Equity of $1.7 million for Q4 2025, down 23.9% sequentially from $2.2 million in Q3 2025, and down 22.65% YoY from $2.1 million in Q4 2024.
Vivos (RDGL) Common Equity (2010 - 2025) Analysis & Trends
Vivos has reported Common Equity for 16 years, with the latest figure at $1.7 million in Q4 2025.
- Quarterly Common Equity fell 22.65% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 22.65% YoY) and the FY2025 annual result came in at $1.7 million, down 22.65% from the prior year.
- Common Equity declined to $1.7 million in Q4 2025 per RDGL's latest filing, from $2.2 million in the prior quarter.
- Over five years, Common Equity peaked at $3.2 million in Q1 2025 and troughed at $893020.0 in Q2 2022.
- A 5-year average of $1.7 million and a median of $1.6 million in 2021 frame the typical range for Common Equity.
- The sharpest annual moves came in 2021 and 2022: Common Equity jumped 4480.7% in 2021, then tumbled 45.06% in 2022.
- Over 5 years, Common Equity stood at $1.5 million in 2021, then climbed by 13.2% to $1.7 million in 2022, then slipped by 17.82% to $1.4 million in 2023, then surged by 57.29% to $2.1 million in 2024, then decreased by 22.65% to $1.7 million in 2025.
- According to Business Quant data, Common Equity over the past three periods registered $1.7 million, $2.2 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 893,020.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.63 Mn |
| Mar 31, 2021 | 1.83 Mn |